Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

SMS Pharmaceuticals Ltd

NSE: SMSPHARMA · BSE: 532815 · Pharmaceuticals & Biotechnology · 9 announcements

Share price
₹475.00
Market cap
₹4,211 Cr
Revenue (annual)
₹886.9 Cr
Net profit (annual)
₹102.0 Cr
P/E (TTM)
41.1×Sector 50.4×
Promoter holding
68.07%+0.00% QoQ
FII holding
0.65%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

13:48 IST BSE
Financial Results

SMS Pharmaceuticals Q4 FY26 Results: Net Profit ₹32.7 Cr, Up 61.1% YoY

SMS Pharmaceuticals Ltd reported revenue from operations of ₹237.9 Cr (-4.1% YoY) and net profit of ₹32.7 Cr (+61.1% YoY) for Q4 FY26.

Key figure
Net profit ₹32.7 Cr · +61.1% YoY